(19)
(11) EP 4 373 559 A1

(12)

(43) Date of publication:
29.05.2024 Bulletin 2024/22

(21) Application number: 22846516.7

(22) Date of filing: 19.07.2022
(51) International Patent Classification (IPC): 
A61M 27/00(2006.01)
A61B 5/03(2006.01)
(52) Cooperative Patent Classification (CPC):
A61M 27/006; A61M 5/1723; A61M 5/16877; A61B 5/032
(86) International application number:
PCT/US2022/037609
(87) International publication number:
WO 2023/003888 (26.01.2023 Gazette 2023/04)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 19.07.2021 US 202163223248 P

(71) Applicant: Enclear Therapies, Inc.
Newburyport MA 01950 (US)

(72) Inventors:
  • PATEL, Rajan
    Newburyport, MA 01950 (US)
  • RICCARDI, Gianna, N.
    Berwick, ME 03908 (US)
  • KALISH, Kevin
    Newburyport, MA 01950 (US)
  • GLICKSMAN, Marcie
    Salem, Massachusetts 01970 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) CSF DIAGNOSTICS PLATFORM